MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jare.2026.07.025

Медицинская библиотека · Journal of advanced research · 2026

Injectable Chito-oligosaccharide-hyaluronic acid hydrogels with Fe3+/AMP nano-enzyme promote ROS scavenging and immunomodulation for myocardial infarction repair.

Chen Lin, Xue Sihan, Zhang Jinde, Wen Xiaofei, Wang Yifan, Liao Wei, Li Ronghui, Du Fengxian, Zhang Shiyao, Wang Qingxiu, Jin Zhaokui, Chen Xiaoyuan, Zhao Qingliang

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

The post-infarction microenvironment, dominated by oxidative stress, hypoxia, and dysregulated inflammation, severely limits cardiac regeneration. Existing injectable hydrogels for myocardial infarction (MI) rarely address these factors simultaneously, and excessive reactive oxygen species (ROS) scavenging may paradoxically cause oxidative damage.

OBJECTIVES

To develop an injectable hydrogel capable of concurrently scavenging ROS, sustaining oxygen release, and modulating immune responses without inducing oxidative damage.

METHODS

A chitosan oligosaccharide-hyaluronic acid hydrogel (C-COS-OHA) was synthesized, incorporating a mild Fe3+/adenosine monophosphate (AMP) nano-enzyme for oxygen generation and redox stability. Carboxyl-modified chitosan oligosaccharide (C-COS) was designed to promote M2 macrophage polarization. The hydrogel was evaluated in vitro for oxidative stress protection and hypoxia tolerance, and in MI mouse models for oxygen retention, inflammation modulation, and cardiac repair.

RESULTS

Compared with catalase (CAT)-loaded hydrogels, C-COS-OHA-Fe3+/AMP enhanced HUVEC survival by 28.9% under oxidative stress and accelerated scratch closure by 26.9% under hypoxia. In vivo, photoacoustic imaging confirmed prolonged oxygen retention; qRT-PCR revealed a 4.1-fold increase in TGF-β expression. After 28  days, MI mice showed 49% reduced fibrosis, 37% thicker ventricular walls, and improved left ventricular ejection fraction (58.3 ± 3.1%), all exceeding C-COS-OHA-CAT performance.

CONCLUSION

The C-COS-OHA-Fe3++/AMP hydrogel integrates ROS scavenging, oxygen modulation, and immunoregulation into a single injectable platform, representing a shift from single-mechanism MI hydrogels to comprehensive microenvironmental regulation for enhanced cardiac regeneration.

Для цитирования: Chen Lin, Xue Sihan, Zhang Jinde, Wen Xiaofei, Wang Yifan, Liao Wei, Li Ronghui, Du Fengxian, Zhang Shiyao, Wang Qingxiu, Jin Zhaokui, Chen Xiaoyuan, Zhao Qingliang. Injectable Chito-oligosaccharide-hyaluronic acid hydrogels with Fe3+/AMP nano-enzyme promote ROS scavenging and immunomodulation for myocardial infarction repair.. Journal of advanced research. 2026. DOI: 10.1016/j.jare.2026.07.025.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.